Novel PTEN germline mutation in a family with mild phenotype: Difficulties in genetic counseling
Highlights
► We report patients with a novel familial PTEN mutation. ► Patients presented a mild phenotype with macrocephaly and learning disabilities. ► The diagnosis led to difficulties in genetic counseling regarding tumor risk.
Introduction
Phosphatase and tensin homolog deleted on chromosome ten (PTEN, MIM 601628) gene is a tumor suppressor gene on 10q23.3. PTEN is implicated in Cowden syndrome (CS), Bannayan–Riley–Ruvalcaba syndrome (BRRS) and Proteus-like syndrome, gathered together in PHTS (PTEN hamartoma tumor syndrome) (Eng, 2003). PTEN gene mutations are thus implicated in both familial cancer predisposition disorders and malformative syndrome with possible mental retardation. There is no genotype–phenotype correlation (Marsh et al., 1999).
Recently, PTEN mutations were reported in children with macrocephaly and autism spectrum disorders or mental retardation or developmental delay (Boccone et al., 2006, Butler et al., 2005, Dasouki et al., 2001, Delatycki et al., 2003, Gorlin et al., 1992, Parisi et al., 2001, Zori et al., 1998). Most of these children did not present other symptoms of PHTS. Subsequent reports found mutations in PTEN in approximately 10% of children with autism spectrum disorders (ASD) and macrocephaly (Buxbaum et al., 2007, Herman et al., 2007, McBride et al., 2010, Orrico et al., 2009, Varga et al., 2009). Although the risk of developing malignancies has not been evaluated for these children and their relatives who carried the same mutation, the authors suggest that all individuals over 18 years should be offered cancer surveillance as currently recommended for CS.
We report a family in which a germline PTEN mutation is associated with macrocephaly and learning disabilities without other symptoms of PHTS or autism.
Section snippets
Patients
The proband (patient III 7, Fig. 1) was referred to our genetic clinic at the age of 8 months for hypotonia and macrocephaly. He was born to healthy nonconsanguineous parents and was the sixth child of his 35 year-old mother (patient II 3, Fig. 1). Two maternal brothers had been previously examined in our department of medical genetics in infancy for hypotonia (patient II 5, Fig. 1) and learning disabilities (patient II 4, Fig. 1). Both had macrocephaly (+ 3 and + 3.5 SD). These patients were
Discussion
The PTEN missense variant (c.402G>C) identified in this family had not been previously reported. However, most PTEN reported mutations are unique to a single individual or family (Bonneau and Longy, 2000). The variant perfectly segregated in the family as it was found in all five affected individuals and absent in the phenotypically normal sister (III 3). Another argument for causality was given by the fact that a mutation in the same codon (p.Met134Leu), responsible for partial reduction of
References (22)
- et al.
The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay and macrocephaly
Genet. Med.
(2009) Bannayan–Riley–Ruvalcaba syndrome with reactive nodular lymphoid hyperplasia and autism and a PTEN mutation
Am. J. Med. Genet. A
(2006)- et al.
Mutations of the human PTEN gene
Hum. Mutat.
(2000) Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations
J. Med. Genet.
(2005)Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly
Am. J. Med. Genet. B Neuropsychiatr. Genet.
(2007)- et al.
Macrocephaly, macrosomia and autistic behavior due to a de novo PTEN germline mutation
Am. J. Hum. Genet. Suppl.
(2001) - et al.
De novo germline PTEN mutation in a man with Lhermitte–Duclos disease which arose on the paternal chromosome and was transmitted to his child with polydactyly and Wormian bones
J. Med. Genet.
(2003) PTEN: one gene, many syndromes
Hum. Mutat.
(2003)- et al.
Bannayan–Riley–Ruvalcaba syndrome
Am. J. Med. Genet.
(1992) Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay
Cancer Res.
(2000)
Bannayan–Riley–Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases
Familial Cancer
Cited by (10)
Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome
2015, European Journal of Paediatric NeurologyCitation Excerpt :PTEN testing showed a de novo nonsense mutation c.1003C > T. Patient 2 and 3, half siblings, were previously reported.3 Patient 2 was referred at age 2 months for isolated macrocephaly which was already noticed during pregnancy.
The First Familiar Case of PTEN-Related Disorder Reported in Albania
2023, Turkish Archives of PediatricsThe Clinical Spectrum of PTEN Mutations
2020, Annual Review of MedicineA subset of autism-associated genes regulate the structural stability of neurons
2016, Frontiers in Cellular NeuroscienceA recessive form of extreme macrocephaly and mild intellectual disability complements the spectrum of PTEN hamartoma tumour syndrome
2016, European Journal of Human GeneticsFunctionally distinct groups of inherited PTEN mutations in autism and tumour syndromes
2015, Journal of Medical Genetics